Amantadyna

December 7, 2021 Off By maja

Artykuł o amantadynie nature.com/articles/s4200…


Praca z grupy Nature https://www.nature.com/articles/s42003-021-02866-9 powołuje się na wiele prac badawczych. Poniżej dokonamy przeglądu części z tych prac cytowanych w artykule.

  1. “All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study” ncbi.nlm.nih.gov/pmc/articles/P…
    a w niej czytamy we wnioskach:
https://pbs.twimg.com/media/FFnz1WuXwA4uH92.png

2. “Rejdak, K. & Grieb, P. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment”

Image

3. Crosby, N. J., Deane, K. & Clarke, C. E. Amantadine for dyskinesia in Parkinson’s disease. Cochrane Database Syst. Rev

Image

4. Aranda-Abreu, G. E. et al. Observational study of people infected with SARS-Cov-2, treated with amantadine. Pharmacol. Rep

Image

5. Fink, K. et al. Amantadine inhibits sars-cov-2 in vitro

Image

6.Structure of the Amantadine Binding Site of Influenza M2 Proton Channels In Lipid Bilayers; Cady et al.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818718/ praca z laboratorium

pozostałe to influenza i ani słowa o SARS-CoV2

Tak więc
gdzie te rekomendacje? oparte na pracy z 22 czy 15 pacjentami?